Clinical Trial Update: Clinical Evaluation on Advanced Resynchronization [Phase 4]

View source ↗

Summary

Phase 4 clinical evaluation of advanced resynchronization therapy conducted by LivaNova has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy (CRT) device system (Cardiac resynchronization therapy device system)

Snippet

Sponsor: LivaNova | Conditions: Heart Failure, Cardiomyopathy | Phase 4 | Status: COMPLETED